Cyclana Bio (ex. Cycle Therapeutics)
Biotechnology Research • 
Cambridge, England, United Kingdom • 1-10 Employees
Company overview
| Headquarters | Cambridge, England, United Kingdom |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
| Socials |
Key Contact at Cyclana Bio (ex. Cycle Therapeutics)
Léa Wenger
Chief Executive Officer and Founder
Cyclana Bio (ex. Cycle Therapeutics) Email Formats
Cyclana Bio (ex. Cycle Therapeutics) uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@cyclanabio.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@cyclanabio.com | 100% |
About Cyclana Bio (ex. Cycle Therapeutics)
Our mission is to cure endometriosis. We are a team of interdisciplinary scientists creating a new model in women's health research centred around an in depth understanding of tissue-level disease processes. We are committed to improving the quality of life of women by providing a new model for therapeutic discovery. We sit at the interface between tissue biology, computation and laboratory disease modelling.
Cyclana Bio (ex. Cycle Therapeutics) revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,100,000 |
| Total funding | $13,600 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Cyclana Bio (ex. Cycle Therapeutics) has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Explore Cyclana Bio (ex. Cycle Therapeutics)'s funding history, including investment rounds, total capital raised, and key backers.
United States
France
GermanyFrequently asked questions
4.8
40,000 users
